Hyderabad-based Mapmygenome raises $1.1 million funding in pre-series A round

Hyderabad-Based MapmyGenome Raises $1.1 Million in Pre-Series A Round

Originally published on YourStory, March 10, 2015.

Indian genomics pioneer MapmyGenome has raised $1.1 million from a group of angel investors in a Pre-Series A round. The company will use the funds to scale up operations and expand distribution locally and globally.

Investors include Aarti Grover MD (CMS Computers), Rajan Anandan MD (Google India), Arihant Patni (Hive Technologies), and Satveer Singh Thakral (CEO, Singapore Angel Network). Avendus Wealth Management Pvt. Ltd. served as advisors for the round.

“This round of funding will help in scaling up our operations in India and globally. We are looking to expand our team where our focus is on quality of talent — education and expertise. We are also looking to invest in some assets and scale up our research.” — Anu Acharya, CEO, MapmyGenome

“With rising affluence and lifestyle changes in India, predictive diagnostics is increasingly becoming a part of the holistic health movement amongst Indians. MapmyGenome has been the pioneer of such testing in India.” — George Mitra, CEO, Avendus Wealth Management

MapmyGenome created a new market category in India for predictive tests with their flagship brand Genomepatri™ in April 2013. The company has tied up with over 38 hospital networks and has started receiving orders from Singapore and Malaysia.